CD9 抗体
Quick Overview for CD9 抗体 (ABIN135677)
抗原
See all CD9 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Human/Hamster/Canine/Feline/Monkey/Rabbit/Raccoon CD9, Mr 24 kDa
-
产品特性
- Mouse Anti-Human CD9-UNLB
-
纯化方法
- Purified
-
免疫原
- Unknown
-
亚型
- IgG2b
-
-
-
-
应用备注
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC and PE conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
说明
-
platelet inhibition and aggregation studies
-
样本量
- 1 mL
-
限制
- 仅限研究用
-
-
-
浓度
- 0.1 mg/mL
-
缓冲液
- 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
-
储存液
- Without preservative
-
注意事项
- Each reagent is stable for the period shown on the bottle label if stored as directed.
-
储存条件
- 4 °C
-
储存方法
- Store at 2-8°C
-
-
-
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." in: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
: "
-
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." in: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
-
- CD9
-
别名
- CD9
-
背景
- CD9 is a 24 kDa member of the transmembrane 4 superfamily (TM4-SF) of cell surface receptors. It is expressed strongly on platelets, lymphoid progenitor cells, activated lymphocytes and endothelia, and, weakly, on eosinophils, granulocytes, monocytes, and macrophages. CD9 functions as an adhesion molecule where it mediates platelet aggregation and activation.
-
途径
- Response to Water Deprivation, Cell-Cell Junction Organization
抗原
-